7) Identifying opportunities to engage in consultations, policy reviews, or federal programs relevant to smoking cessation or health innovation. 6) Providing timely information and scientific context related to harm reduction and nicotine pouches; 5) Promoting policy and regulatory approaches that support innovation in smoking cessation 4) Facilitating engagement with Members of Parliament, political staff, and relevant officials at Health Canada, Finance Canada, and the Privy Council Office Targeted Public Office Holders 3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco. 2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada. 1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).